Global Microsclerotherapy Treatment Market is Likely to Grow at a CAGR Value of 3.0% By 2028

The global microsclerotherapy treatment market size was worth USD 6,829.4 million in 2021 and is estimated to grow to USD 8,154.6 million by 2028, with a compound annual growth rate (CAGR) of approximately 3.0 percent during the forecast period. The report analyzes the microsclerotherapy treatment market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the microsclerotherapy treatment market.

Thread veins or Spider veins are extremely thin, microscopic veins visible beneath the skin and appear like a spider web. Small varicose veins are another name for spider veins. They result from the veins' valves failing, which causes them. Swelling results from the blood droplets backing up in the veins. Microsclerotherapy is one of the most effective treatments for spider veins.

Telangiectasia, a disorder where ruptured blood vessels close to the surface or mucous membrane appear as red or pink lines on the skin surface, is treated with microsclerotherapy. Both genetic and environmental factors influence Telangiectasia. Telangiectasia may also be brought on by aging, pregnancy, rosacea, excessive sun exposure, and varicose veins. Although there is no treatment for this illness, it can be managed using microsclerotherapy.

One of the primary driving factors influencing the growth of the global microsclerotherapy treatment market is the increasing prevalence of spider and varicose veins. The key factors driving the development of the global industry during the projected period will be the treatment's relative lack of discomfort, low intrusion, high effectiveness, decreased post-operative problems, and the straightforward analgesic needed during the process.

Growth in the geriatric populace is another aspect that can favorably impact the global market since spider veins are more common in the aging population. Moreover, heritability, the occurrence of unhealthy habits, and obesity are factors that may have an impact on the global growth of microsclerotherapy treatment. Higher treatment costs, a lack of surgeon training, and other alternative procedures are a few of the major factors that may restrict the microsclerotherapy treatment market's expansion throughout the forecast period.

The global microsclerotherapy treatment market is segregated based on product type, end-users, and region. Based on product type, the market is divided into sclerosants, sodium tetradecyl sulphate, polidocanol, chromated glycerin, hypertonic glucose, needles, and others. Among these, the sclerosants segment led the market in 2021 and is expected to maintain its dominance throughout the forecast period. Based on end-users, the market is classified into hospitals, aesthetic treatment clinics, and others. In 2021, the hospital category dominated the global market.

The global microsclerotherapy treatment market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Due to advanced healthcare facilities, an increasing emphasis on aesthetics, persistent lifestyle modifications, the prevalence of varicose veins, and a rise in disposable income, North America is anticipated to have a dominating position in the worldwide market for microsclerotherapy treatment during the forecast period. Varicose veins affect around 23% of individuals in the United States, according to Clinical Epidemiology Reports 2021.

The prevalence increases to 80% in males and 85% in women when spiders' telangiectasias and reticular veins are considered. One in 22 of the cases included the United States. Thus, the rising prevalence of spider veins in the American people will likely boost the demand in the region during the forecast period. Additionally, between 2022 and 2028, the market in the Asia Pacific is anticipated to develop at the greatest CAGR.

The region's market is predicted to be propelled by an increase in the senior population, an increase in the number of obese people, and a preference for minimally invasive methods for treating varicose veins.

According to recent reports, a sedentary lifestyle causes varicose veins in 7% of India's young people. In nations like China, 40% of the 100 million people with varicosities had lower leg varicose veins. The market in the Asia Pacific is also anticipated to be driven by these factors over the projected period.

Key players in the global microsclerotherapy treatment market include Merz Pharma GmbH & Co. KGaA, Surgimedix Inc, Troikaa, QOL Medical LLC, McKesson Corporation, Kreussler Inc, Provensis, ltd, Omega Pharmaceuticals, STD Pharmaceuticals Product Ltd, Medtronic Plc, Endo-Flex, Boston Scientific Corporation, and Teleflex Incorporated.

Recent Development:

• April 2022: I-VASC, an Italian healthcare device firm, received a EUR 1.8 million series of funding for launching its VELEX tool. VELEX, which has acquired CE mark approval, is a tool that can be used to cure varicose and CVI veins through a process known as Empty Venous Ablation (EVA).
• December 2021: BD purchased Venclose to enter the microsclerotherapy and varicose veins treatment market.

Browse the full “Microsclerotherapy Treatment Market By Product Type (Sclerosants, Sodium Tetradecyl Sulphate, Polidocanol, Chromated Glycerin, Hypertonic Glucose, Needles, Others), By End Users (Hospitals, Aesthetic Treatment Clinics, Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/microsclerotherapy-treatment-market

Global Microsclerotherapy Treatment Market is segmented as follows:

By Product Type

• Sclerosants
• Sodium Tetradecyl Sulphate
• Polidocanol
• Chromated Glycerin
• Hypertonic Glucose
• Needles
• Others

By End Users

• Hospitals
• Aesthetic Treatment Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com